Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPRIT: Effect of Hemoglobin Levels on Renal Function in Transplant Patients
NCT00396435Phase 4Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- Apr 2004
- Primary completion
- Apr 2009
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of epoetin beta in anemia (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Estimated Creatinine Clearance (Cockcroft-Gault) at 2 years. Started Apr 2004; status: completed.
02
Drugs
epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00396435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396435.